167 related articles for article (PubMed ID: 31698611)
1. Exome sequencing identifies predisposing and fusion gene in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
Wu W; Xu WJ; Liu JB; Sun J; Huang YM; Lv ZB
Math Biosci Eng; 2019 Aug; 16(6):7217-7229. PubMed ID: 31698611
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics of ganglioneuroma and ganglioneuroblastoma: a report from the CCG and COG.
Okamatsu C; London WB; Naranjo A; Hogarty MD; Gastier-Foster JM; Look AT; LaQuaglia M; Maris JM; Cohn SL; Matthay KK; Seeger RC; Saji T; Shimada H
Pediatr Blood Cancer; 2009 Oct; 53(4):563-9. PubMed ID: 19530234
[TBL] [Abstract][Full Text] [Related]
3. Role of diffusion-weighted imaging in distinguishing thoracoabdominal neuroblastic tumours of various histological types and differentiation grades.
Wen Y; Peng Y; Duan XM; Zhang N
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):718-724. PubMed ID: 28508462
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors.
Neubauer H; Li M; Müller VR; Pabst T; Beer M
Rofo; 2017 Jul; 189(7):640-650. PubMed ID: 28511265
[No Abstract] [Full Text] [Related]
5. Characteristics of benign neuroblastic tumors: Is surgery always necessary?
Whitlock RS; Mehl SC; Larson SK; Foster JH; Hicks J; Nuchtern JG; Sher AC; Vasudevan SA; Naik-Mathuria B
J Pediatr Surg; 2022 Aug; 57(8):1538-1543. PubMed ID: 34281709
[TBL] [Abstract][Full Text] [Related]
6. [Molecular genetic abnormalities of N-myc and C-myc in pediatric neuroblastic tumors and clinical pathologic significance].
Cai RQ; Zhou CJ; Sun QN; Ma XL; Wang M; Li Y; Wang DY; Gong LP
Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):299-304. PubMed ID: 24004585
[TBL] [Abstract][Full Text] [Related]
7. Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Goto S; Umehara S; Gerbing RB; Stram DO; Brodeur GM; Seeger RC; Lukens JN; Matthay KK; Shimada H
Cancer; 2001 Nov; 92(10):2699-708. PubMed ID: 11745206
[TBL] [Abstract][Full Text] [Related]
8. Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification.
Koshy A; Jain R; Srinivasan R; Bhatia P; Kakkar N; Rajwanshi A; Gupta N; Dey P; Trehan A; Bansal D
Cytopathology; 2019 Nov; 30(6):634-643. PubMed ID: 31231909
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents.
Alexander N; Sullivan K; Shaikh F; Irwin MS
Pediatr Blood Cancer; 2018 May; 65(5):e26964. PubMed ID: 29369484
[TBL] [Abstract][Full Text] [Related]
10. ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours.
Wilzén A; Krona C; Sveinbjörnsson B; Kristiansson E; Dalevi D; Øra I; De Preter K; Stallings RL; Maris J; Versteeg R; Nilsson S; Kogner P; Abel F
Mol Cancer; 2013 Jul; 12(1):70. PubMed ID: 23835063
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of delta-like gene and protein in neuroblastoma, ganglioneuroblastoma and ganglioneuroma.
Hsiao CC; Huang CC; Sheen JM; Tai MH; Chen CM; Huang LL; Chuang JH
Mod Pathol; 2005 May; 18(5):656-62. PubMed ID: 15605081
[TBL] [Abstract][Full Text] [Related]
12. Brain lipid-binding protein: a marker of differentiation in neuroblastic tumors.
Retrosi G; Sebire NJ; Bishay M; Kiely EM; Anderson J; De Coppi P; Resca E; Rampling D; Bier N; Mills K; Eaton S; Pierro A
J Pediatr Surg; 2011 Jun; 46(6):1197-200. PubMed ID: 21683222
[TBL] [Abstract][Full Text] [Related]
13. Treatment and outcome of Ganglioneuroma and Ganglioneuroblastoma intermixed.
Decarolis B; Simon T; Krug B; Leuschner I; Vokuhl C; Kaatsch P; von Schweinitz D; Klingebiel T; Mueller I; Schweigerer L; Berthold F; Hero B
BMC Cancer; 2016 Jul; 16():542. PubMed ID: 27465021
[TBL] [Abstract][Full Text] [Related]
14. Extra-adrenal peripheral neuroblastic tumors: A clinicopathological study of 18 cases.
Shankaralingappa S; Patra S; Gami A; Trivedi P; Chalaliya AK
Indian J Pathol Microbiol; 2023; 66(2):278-285. PubMed ID: 37077068
[TBL] [Abstract][Full Text] [Related]
15. Whole-tumor radiomics analysis of T2-weighted imaging in differentiating neuroblastoma from ganglioneuroblastoma/ganglioneuroma in children: an exploratory study.
Wang H; Chen X; Yu W; Xie M; Zhang L; Ding H; Li T; Qin J; He L
Abdom Radiol (NY); 2023 Apr; 48(4):1372-1382. PubMed ID: 36892608
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data.
Tabyaoui I; Tahiri-Jouti N; Serhier Z; Bennani-Othmani M; Sibai H; Itri M; Benchekroun S; Zamiati S
Diagn Pathol; 2013 Feb; 8():39. PubMed ID: 23445749
[TBL] [Abstract][Full Text] [Related]
17. Single nucleotide polymorphism rs11669203 in TGFBR3L is associated with the risk of neuroblastoma in a Chinese population.
Jin Y; Wang H; Han W; Lu J; Chu P; Han S; Ni X; Ning B; Yu D; Guo Y
Tumour Biol; 2016 Mar; 37(3):3739-47. PubMed ID: 26468016
[TBL] [Abstract][Full Text] [Related]
18. A Metastatic Neuroblastic Tumor in a 28-Month-old Boy: Unusual Spontaneous Regression From Neuroblastoma to Ganglioneuroma?
Yamada A; Kinoshita M; Kamimura S; Nakame K; Moritake H
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e589-e592. PubMed ID: 34054050
[TBL] [Abstract][Full Text] [Related]
19. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.
Shimada H; Umehara S; Monobe Y; Hachitanda Y; Nakagawa A; Goto S; Gerbing RB; Stram DO; Lukens JN; Matthay KK
Cancer; 2001 Nov; 92(9):2451-61. PubMed ID: 11745303
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y- and somatostatin-like immunoreactivities in ganglioneuroma, ganglioneuroblastoma and neuroblastoma.
Takahashi K; Mouri T; Itoi K; Sone M; Hayashi Y; Murakami O; Ohneda M; Ohi R; Yoshinaga K
Endocrinol Jpn; 1989 Oct; 36(5):627-33. PubMed ID: 2620662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
